Clonal dynamics and somatic evolution of haematopoiesis in mouse.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Haematopoietic stem cells maintain blood production throughout life1. Although extensively characterized using the laboratory mouse, little is known about clonal selection and population dynamics of the haematopoietic stem cell pool during murine ageing. We isolated stem cells and progenitors from young and old mice, identifying 221,890 somatic mutations genome-wide in 1,845 single-cell-derived colonies. Mouse stem cells and progenitors accrue approximately 45 somatic mutations per year, a rate only approximately threefold greater than human progenitors despite the vastly different organismal sizes and lifespans. Phylogenetic patterns show that stem and multipotent progenitor cell pools are established during embryogenesis, after which they independently self-renew in parallel over life, evenly contributing to differentiated progenitors and peripheral blood. The stem cell pool grows steadily over the mouse lifespan to about 70,000 cells, self-renewing about every 6 weeks. Aged mice did not display the profound loss of clonal diversity characteristic of human haematopoietic ageing. However, targeted sequencing showed small, expanded clones in the context of murine ageing, which were larger and more numerous following haematological perturbations, exhibiting a selection landscape similar to humans. Our data illustrate both conserved features of population dynamics of blood and distinct patterns of age-associated somatic evolution in the short-lived mouse.
Description
Acknowledgements: C.D.K. is supported by grant no. F30DK131638 and is a visiting scholar at the Wellcome Sanger Institute. The Goodell lab is supported by grants from the National Institutes of Health, including grant nos. AG036695, CA183252, CA237291, DK092883, 1P01CA265748, F30HD111129 (S.W.) and the Milky Way Research Foundation. J.N. is supported by a Cancer Research UK Advanced Clinical Fellowship, and work in the Nangalia lab is supported by Wellcome, Cancer Research UK, Alborada Trust, Blood Cancer UK, Leukemia and Lymphoma Society, and the WBH Foundation. L.J.N. is supported by NIH grant nos. AG063543 and AG056278. The Niedernhofer lab is supported by grant nos. AG063543 and AG063543-02S1. The Harrison lab is supported by grant no. 5U01AG022308. D. Le, M.A.F. and K.Y.K. were supported by grant nos. R35 HL155672 (K.Y.K.), R01 AI141716 (K.Y.K.), F31 HL154661 (D. Le), F31 HL156500 (M.A.F.) and a minority graduate fellowship from the American Society of Hematology (M.A.F.). K.N. is supported by the Wellcome Trust and CRUK. Adobe Stock library images used in illustrations were covered under a Baylor College of Medicine education license. We are grateful for the assistance of R. D. O’Kelly and M. Pierson in conducting NME experiments and the CASM Support team at the Wellcome Sanger Institute. We thank E. Laurenti, S. Loughran and A. R. Green for constructive discussions and J. T. Gebert and H. L. Chan for the critical feedback.
Keywords
Journal Title
Conference Name
Journal ISSN
1476-4687

